Related references
Note: Only part of the references are listed.Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2019)
Association Between Insulin-Like Growth Factor-1 and Frailty Among Older Adults
T. Doi et al.
JOURNAL OF NUTRITION HEALTH & AGING (2018)
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
M. Pirruccello-Straub et al.
SCIENTIFIC REPORTS (2018)
Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men
Elizaveta Fife et al.
BMC GERIATRICS (2018)
International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management
E. Dent et al.
JOURNAL OF NUTRITION HEALTH & AGING (2018)
Insulin-Like Growth Factor-1 Related to Disability Among Older Adults
Takehiko Doi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
Marissa J. Schafer et al.
CELL METABOLISM (2016)
Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
Beatriz Garcia-Fontana et al.
ENDOCRINE (2016)
The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion
M. Zuegel et al.
ENDOCRINE (2016)
Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults
L. Tay et al.
AGE (2015)
Sarcopenia as the Biological Substrate of Physical Frailty
Francesco Landi et al.
CLINICS IN GERIATRIC MEDICINE (2015)
Biomarkers for physical frailty and sarcopenia: state of the science and future developments
Riccardo Calvani et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay
H. Robert Bergen et al.
SKELETAL MUSCLE (2015)
Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease
Jwa-Kyung Kim et al.
CLINICAL NUTRITION (2014)
Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
Thomas A. White et al.
GERONTOLOGY (2014)
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Mortality as an adverse outcome of sarcopenia
V. E. Arango-Lopera et al.
JOURNAL OF NUTRITION HEALTH & AGING (2013)
Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women
Diana G. Taekema et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men
A. Ratkevicius et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
NUTRITIONAL ASSESSMENT IN AN ASIAN NURSING HOME AND ITS ASSOCIATION WITH MORTALITY
M. Chan et al.
JOURNAL OF NUTRITION HEALTH & AGING (2010)
Defining Sarcopenia in Terms of Risk of Physical Limitations: A 5-Year Follow-Up Study of 3,153 Chinese Men and Women
Jean Woo et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Identification of a novel pool of extracellular pro-myostatin in skeletal muscle
Sarah B. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of akt phosphorylation
Bertrand Leger et al.
REJUVENATION RESEARCH (2008)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study
R Roubenoff et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Frailty in older adults: Evidence for a phenotype
LP Fried et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)
Share Paper
